Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (6534)
All Articles published online
|
Oct 7, 2010 (publication date) through Nov 22, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Zhan YT, An W. Roles of liver innate immune cells in nonalcoholic fatty liver disease. World J Gastroenterol 2010; 16(37): 4652-4660 [PMID: 20872965 DOI: 10.3748/wjg.v16.i37.4652] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v16/i37/4652.htm |
| Number | Citing Articles |
| 1 |
Nancy Magee, An Zou, Yuxia Zhang. Pathogenesis of Nonalcoholic Steatohepatitis: Interactions between Liver Parenchymal and Nonparenchymal Cells. BioMed Research International 2016; 2016: 1 doi: 10.1155/2016/5170402
|
| 2 |
Wing Pak, Fusako Takayama, Manaka Mine, Kazuo Nakamoto, Yasumasa Kodo, Mitsumasa Mankura, Toru Egashira, Hiromu Kawasaki, Akitane Mori. Anti-oxidative and anti-inflammatory effects of spirulina on rat model of non-alcoholic steatohepatitis. Journal of Clinical Biochemistry and Nutrition 2012; doi: 10.3164/jcbn.12-18
|
| 3 |
Zahra Moayedfard, Farnaz Sani, Aliakbar Alizadeh, Kamran Bagheri Lankarani, Mohammad Zarei, Negar Azarpira. The role of the immune system in the pathogenesis of NAFLD and potential therapeutic impacts of mesenchymal stem cell-derived extracellular vesicles. Stem Cell Research & Therapy 2022; 13(1) doi: 10.1186/s13287-022-02929-6
|
| 4 |
H M Kim, B R Lee, E S Lee, M H Kwon, J H Huh, B-E Kwon, E-K Park, S-Y Chang, M-N Kweon, P-H Kim, H-J Ko, C H Chung. iNKT cells prevent obesity-induced hepatic steatosis in mice in a C-C chemokine receptor 7-dependent manner. International Journal of Obesity 2018; 42(2): 270 doi: 10.1038/ijo.2017.200
|
| 5 |
Tatjana Sajic, Alexandre Hainard, Alexander Scherl, Annelise Wohlwend, Francesco Negro, Jean-Charles Sanchez, Ildiko Szanto. STAT6 promotes bi-directional modulation of PKM2 in liver and adipose inflammatory cells in Rosiglitazone-treated mice. Scientific Reports 2013; 3(1) doi: 10.1038/srep02350
|
| 6 |
Siow-Wey Hee, Yi-Cheng Chang, Lynn Su, Ing-Jung Chen, Yung-Ming Jeng, Meng-Lun Hsieh, Yu-Chia Chang, Fu-An Li, Daniel Liao, Shiau-Mei Chen, Lee-Ming Chuang. 15-keto-PGE2 alleviates nonalcoholic steatohepatitis through its covalent modification of NF-κB factors. iScience 2023; 26(10): 107997 doi: 10.1016/j.isci.2023.107997
|
| 7 |
Yusuf Yilmaz. Cytokeratins in hepatitis. Clinica Chimica Acta 2011; 412(23-24): 2031 doi: 10.1016/j.cca.2011.09.002
|
| 8 |
Yuneivy Cepero-Donates, Grégory Lacraz, Farnaz Ghobadi, Volatiana Rakotoarivelo, Sakina Orkhis, Marian Mayhue, Yi-Guang Chen, Marek Rola-Pleszczynski, Alfredo Menendez, Subburaj Ilangumaran, Sheela Ramanathan. Interleukin-15-mediated inflammation promotes non-alcoholic fatty liver disease. Cytokine 2016; 82: 102 doi: 10.1016/j.cyto.2016.01.020
|
| 9 |
Keisuke Sawada, Hak Chung, Samir Softic, Maria E. Moreno-Fernandez, Senad Divanovic. The bidirectional immune crosstalk in metabolic dysfunction-associated steatotic liver disease. Cell Metabolism 2023; 35(11): 1852 doi: 10.1016/j.cmet.2023.10.009
|
| 10 |
Hyunhee Cheong, Seung Soo Lee, Jin Seong Lee, Jihoon Kim, Seong Who Kim, Woo Je Lee. Phagocytic function of Kupffer cells in mouse nonalcoholic fatty liver disease models: Evaluation with superparamagnetic iron oxide. Journal of Magnetic Resonance Imaging 2015; 41(5): 1218 doi: 10.1002/jmri.24674
|
| 11 |
Daiane Gonçalves de Oliveira, Fabiana de Faria Ghetti, Ana Paula Boroni Moreira, Helen Hermana Miranda Hermsdorff, Juliano Machado de Oliveira, Lincoln Eduardo Villela Vieira de Castro Ferreira. Association between dietary total antioxidant capacity and hepatocellular ballooning in nonalcoholic steatohepatitis: a cross-sectional study. European Journal of Nutrition 2019; 58(6): 2263 doi: 10.1007/s00394-018-1776-0
|
| 12 |
Moon Young Kim. The Progression of Liver Fibrosis in Non-alcoholic Fatty Liver Disease. The Korean Journal of Gastroenterology 2017; 69(6): 341 doi: 10.4166/kjg.2017.69.6.341
|
| 13 |
Hammad Ahmed, Muhammad Ihtisham Umar, Salman Imran, Faraza Javaid, Shahzada Khurram Syed, Romana Riaz, Waseem Hassan. TGF-β1 signaling can worsen NAFLD with liver fibrosis backdrop. Experimental and Molecular Pathology 2022; 124: 104733 doi: 10.1016/j.yexmp.2021.104733
|
| 14 |
Linyu Pan, Ze Yu, Xiaolin Liang, Jiyou Yao, Yanfang Fu, Xu He, Xiaoling Ren, Jiajia Chen, Xuejuan Li, Minqiang Lu, Tian Lan. Sodium cholate ameliorates nonalcoholic steatohepatitis by activation of FXR signaling. Hepatology Communications 2023; 7(2): e0039 doi: 10.1097/HC9.0000000000000039
|
| 15 |
Javier Angeles-Martínez, Rosalinda Posadas-Sánchez, Nonanzit Pérez-Hernández, José Manuel Rodríguez-Pérez, José Manuel Fragoso, Eyerahi Bravo-Flores, Carlos Posadas-Romero, Gilberto Vargas-Alarcón. IL-15 polymorphisms are associated with subclinical atherosclerosis and cardiovascular risk factors. The Genetics of Atherosclerosis Disease (GEA) Mexican Study. Cytokine 2017; 99: 173 doi: 10.1016/j.cyto.2017.09.006
|
| 16 |
Jessica R. Goree, Elise G. Lavoie, Michel Fausther, Jonathan A. Dranoff. Expression of mediators of purinergic signaling in human liver cell lines. Purinergic Signalling 2014; 10(4): 631 doi: 10.1007/s11302-014-9425-4
|
| 17 |
Yutao Zhan, Fei Zhao, Ping Xie, Leping Zhong, Dongnian Li, Qujing Gai, Li Li, Hongshan Wei, Lingqiang Zhang, Wei An. Mechanism of the effect of glycosyltransferase GLT8D2 on fatty liver. Lipids in Health and Disease 2015; 14(1) doi: 10.1186/s12944-015-0040-3
|
| 18 |
Nannan Sun, Chuangpeng Shen, Lei Zhang, Xiaojie Wu, Yuanyuan Yu, Xiaoying Yang, Chen Yang, Chong Zhong, Zhao Gao, Wei Miao, Zehong Yang, Weihang Gao, Ling Hu, Kevin Williams, Changhui Liu, Yongsheng Chang, Yong Gao. Hepatic Krüppel-like factor 16 (KLF16) targets PPARα to improve steatohepatitis and insulin resistance. Gut 2021; 70(11): 2183 doi: 10.1136/gutjnl-2020-321774
|
| 19 |
Xue Ding, Peng-Fei Meng, Xiu-Xia Ma, Jing-Yu Yue, Liang-Ping Li, Li-Ran Xu. Akkermansia muciniphila and herbal medicine in immune-related diseases: current evidence and future perspectives. Frontiers in Microbiomes 2024; 3 doi: 10.3389/frmbi.2024.1276015
|
| 20 |
Kara W. Chew, Debika Bhattacharya. Virologic and immunologic aspects of HIV–hepatitis C virus coinfection. AIDS 2016; 30(16): 2395 doi: 10.1097/QAD.0000000000001203
|
| 21 |
Alvaro Santos-Laso, María Gutiérrez-Larrañaga, Marta Alonso-Peña, Juan M. Medina, Paula Iruzubieta, María Teresa Arias-Loste, Marcos López-Hoyos, Javier Crespo. Pathophysiological Mechanisms in Non-Alcoholic Fatty Liver Disease: From Drivers to Targets. Biomedicines 2021; 10(1): 46 doi: 10.3390/biomedicines10010046
|
| 22 |
A. G. Ramakrishnan, Kanishka Sharma. Factors behind higher COVID-19 recovery and lower fatality rates in India - need for a focused study. 2021 IEEE 9th Region 10 Humanitarian Technology Conference (R10-HTC) 2021; : 1 doi: 10.1109/R10-HTC53172.2021.9641736
|
| 23 |
Hong-Shan Wei, Hong-Lian Wei, Fei Zhao, Le-Ping Zhong, Yu-Tao Zhan. Glycosyltransferase GLT8D2 Positively Regulates ApoB100 Protein Expression in Hepatocytes. International Journal of Molecular Sciences 2013; 14(11): 21435 doi: 10.3390/ijms141121435
|
| 24 |
Bertrand Cariou, Bart Staels. GFT505 for the treatment of nonalcoholic steatohepatitis and type 2 diabetes. Expert Opinion on Investigational Drugs 2014; 23(10): 1441 doi: 10.1517/13543784.2014.954034
|
| 25 |
Y Ilan, K Shailubhai, A Sanyal. Immunotherapy with oral administration of humanized anti-CD3 monoclonal antibody: a novel gut-immune system-based therapy for metaflammation and NASH. Clinical and Experimental Immunology 2018; 193(3): 275 doi: 10.1111/cei.13159
|
| 26 |
Priya Handa, Kris V. Kowdley. Dendritic cells in NASH: Friend or foe?. Annals of Hepatology 2013; 12(3): 508 doi: 10.1016/S1665-2681(19)31018-X
|
| 27 |
M. G. M. Pruis, Á. Lendvai, V. W. Bloks, M. V. Zwier, J. F. W. Baller, A. de Bruin, A. K. Groen, T. Plösch. Maternal western diet primes non‐alcoholic fatty liver disease in adult mouse offspring. Acta Physiologica 2014; 210(1): 215 doi: 10.1111/apha.12197
|
| 28 |
Reza Meshkani, Sanaz Vakili. Tissue resident macrophages: Key players in the pathogenesis of type 2 diabetes and its complications. Clinica Chimica Acta 2016; 462: 77 doi: 10.1016/j.cca.2016.08.015
|
| 29 |
Julia Phieler, Ruben Garcia-Martin, John D. Lambris, Triantafyllos Chavakis. The role of the complement system in metabolic organs and metabolic diseases. Seminars in Immunology 2013; 25(1): 47 doi: 10.1016/j.smim.2013.04.003
|
| 30 |
Beihui He, Liyan Wu, Wei Xie, Yitong Shao, Jianping Jiang, Zhenzhong Zhao, Maoxiang Yan, Zhiyun Chen, Dawei Cui. The imbalance of Th17/Treg cells is involved in the progression of nonalcoholic fatty liver disease in mice. BMC Immunology 2017; 18(1) doi: 10.1186/s12865-017-0215-y
|
| 31 |
María Eugenia Inzaugarat, Nazarena Eugenia Ferreyra Solari, Luis Ariel Billordo, Raquel Abecasis, Adrian C. Gadano, Alejandra Claudia Cherñavsky. Altered Phenotype and Functionality of Circulating Immune Cells Characterize Adult Patients with Nonalcoholic Steatohepatitis. Journal of Clinical Immunology 2011; 31(6): 1120 doi: 10.1007/s10875-011-9571-1
|
| 32 |
Nicole K. H. Yiew, Brian N. Finck. The mitochondrial pyruvate carrier at the crossroads of intermediary metabolism. American Journal of Physiology-Endocrinology and Metabolism 2022; 323(1): E33 doi: 10.1152/ajpendo.00074.2022
|
| 33 |
Tatsuhiro Tsujimoto, Hideto Kawaratani, Toshiyuki Kitazawa, Masahito Uemura, Hiroshi Fukui. Innate Immune Reactivity of the Ileum–Liver Axis in Nonalcoholic Steatohepatitis. Digestive Diseases and Sciences 2012; 57(5): 1144 doi: 10.1007/s10620-012-2073-z
|
| 34 |
Samar H. Gerges, Sara A. Wahdan, Doaa A. Elsherbiny, Ebtehal El-Demerdash. Non-alcoholic fatty liver disease: An overview of risk factors, pathophysiological mechanisms, diagnostic procedures, and therapeutic interventions. Life Sciences 2021; 271: 119220 doi: 10.1016/j.lfs.2021.119220
|
| 35 |
Megan Crane, David Iser, Sharon R Lewin. Human immunodeficiency virus infection and the liver. World Journal of Hepatology 2012; 4(3): 91-98 doi: 10.4254/wjh.v4.i3.91
|
| 36 |
Kira Bettermann, Tabea Hohensee, Johannes Haybaeck. Steatosis and Steatohepatitis: Complex Disorders. International Journal of Molecular Sciences 2014; 15(6): 9924 doi: 10.3390/ijms15069924
|
| 37 |
Alok Kumar Pandey, Vishal Trivedi. Heat shock protein HSPA8 impedes hemin-induced cellular-toxicity in liver. Toxicology in Vitro 2025; 102: 105959 doi: 10.1016/j.tiv.2024.105959
|
| 38 |
Junji Nagano, Masahito Shimizu, Takeshi Hara, Yohei Shirakami, Takahiro Kochi, Nobuhiko Nakamura, Hirofumi Ohtaki, Hiroyasu Ito, Takuji Tanaka, Hisashi Tsurumi, Kuniaki Saito, Mitsuru Seishima, Hisataka Moriwaki, Rafael Aldabe. Effects of Indoleamine 2,3-Dioxygenase Deficiency on High-Fat Diet-Induced Hepatic Inflammation. PLoS ONE 2013; 8(9): e73404 doi: 10.1371/journal.pone.0073404
|
| 39 |
Stergios A. Polyzos, Jannis Kountouras, Christos Zavos, Georgia Deretzi. Nonalcoholic Fatty Liver Disease. Journal of Clinical Gastroenterology 2012; 46(4): 272 doi: 10.1097/MCG.0b013e31824587e0
|
| 40 |
Yusuf Yilmaz, Yasar Colak, Ramazan Kurt, Ebubekir Senates, Fatih Eren. Linking Nonalcoholic Fatty Liver Disease to Hepatocellular Carcinoma: From Bedside to Bench and Back. Tumori Journal 2013; 99(1): 10 doi: 10.1177/030089161309900102
|
| 41 |
Y. Yilmaz. Review article: is non‐alcoholic fatty liver disease a spectrum, or are steatosis and non‐alcoholic steatohepatitis distinct conditions?. Alimentary Pharmacology & Therapeutics 2012; 36(9): 815 doi: 10.1111/apt.12046
|
| 42 |
Yuting Fan, Wendi Zhang, Haiming Wei, Rui Sun, Zhigang Tian, Yongyan Chen. Hepatic NK cells attenuate fibrosis progression of non‐alcoholic steatohepatitis in dependent of CXCL10‐mediated recruitment. Liver International 2020; 40(3): 598 doi: 10.1111/liv.14307
|
| 43 |
Yingyi Huang, Xiang Liu, Hong-Yan Wang, Jian-Yang Chen, Xianghui Zhang, Yubang Li, Yifang Lu, Zhongdian Dong, Kaiqiang Liu, Zhongduo Wang, Qian Wang, Guangyi Fan, Jun Zou, Shanshan Liu, Changwei Shao. Single-cell transcriptome landscape of zebrafish liver reveals hepatocytes and immune cell interactions in understanding nonalcoholic fatty liver disease. Fish & Shellfish Immunology 2024; 146: 109428 doi: 10.1016/j.fsi.2024.109428
|
| 44 |
Darmadi Darmadi, Riska Habriel Ruslie. Association between serum interleukin (IL)-12 level and severity of non-alcoholic fatty liver disease (NAFLD). Romanian Journal of Internal Medicine 2021; 59(1): 66 doi: 10.2478/rjim-2020-0029
|
| 45 |
Qian Ren, Hongya Wang, Yan Zeng, Xia Fang, Mei Wang, Dongze Li, Wei Huang, Yong Xu. Circulating chemerin levels in metabolic-associated fatty liver disease: a systematic review and meta-analysis. Lipids in Health and Disease 2022; 21(1) doi: 10.1186/s12944-022-01637-7
|
| 46 |
Erin E Bryan, Xuenan Chen, Brooke Nicole Smith, Ryan Neil Dilger, Anna C Dilger. Maternal immune activation and dietary soy isoflavone supplementation influence pig immune function but not muscle fiber formation. Journal of Animal Science 2022; 100(5) doi: 10.1093/jas/skac134
|
| 47 |
Harmeet Malhi, Erin M. Kropp, Vinna F. Clavo, Christina R. Kobrossi, JaeSeok Han, Amy S. Mauer, Jing Yong, Randal J. Kaufman. C/EBP Homologous Protein-induced Macrophage Apoptosis Protects Mice from Steatohepatitis. Journal of Biological Chemistry 2013; 288(26): 18624 doi: 10.1074/jbc.M112.442954
|
| 48 |
Srikanth Iyer, Pramod Kumar Upadhyay, Subeer S. Majumdar, Perumal Nagarajan. Animal Models Correlating Immune Cells for the Development of NAFLD/NASH. Journal of Clinical and Experimental Hepatology 2015; 5(3): 239 doi: 10.1016/j.jceh.2015.06.004
|
| 49 |
Sébastien Lepreux, Julien Villeneuve, Antoine Dewitte, Annie M. Bérard, Alexis Desmoulière, Jean Ripoche. CD40 signaling and hepatic steatosis: Unanticipated links. Clinics and Research in Hepatology and Gastroenterology 2017; 41(4): 357 doi: 10.1016/j.clinre.2016.11.002
|
| 50 |
Howard C. Masuoka, Naga Chalasani. Nonalcoholic fatty liver disease: an emerging threat to obese and diabetic individuals. Annals of the New York Academy of Sciences 2013; 1281(1): 106 doi: 10.1111/nyas.12016
|
| 51 |
Fenglei Li, Xiaolei Hao, Yongyan Chen, Li Bai, Xiang Gao, Zhexiong Lian, Haiming Wei, Rui Sun, Zhigang Tian. The microbiota maintain homeostasis of liver-resident γδT-17 cells in a lipid antigen/CD1d-dependent manner. Nature Communications 2017; 8(1) doi: 10.1038/ncomms13839
|
| 52 |
Amnon Schlegel. Studying non-alcoholic fatty liver disease with zebrafish: a confluence of optics, genetics, and physiology. Cellular and Molecular Life Sciences 2012; 69(23): 3953 doi: 10.1007/s00018-012-1037-y
|
| 53 |
William Peverill, Lawrie Powell, Richard Skoien. Evolving Concepts in the Pathogenesis of NASH: Beyond Steatosis and Inflammation. International Journal of Molecular Sciences 2014; 15(5): 8591 doi: 10.3390/ijms15058591
|
| 54 |
Homa Khaleghzadeh, Mohammad Esmaeil Afzalpour, Mohsen Mohammadnia Ahmadi, Mohsen Nematy, Mohammad Ali Sardar. Effect of high intensity interval training along with Oligopin supplementation on some inflammatory indices and liver enzymes in obese male Wistar rats with non-alcoholic fatty liver disease. Obesity Medicine 2020; 17: 100177 doi: 10.1016/j.obmed.2019.100177
|
| 55 |
Kira L. Diehl, Julia Vorac, Kristina Hofmann, Philippa Meiser, Iris Unterweger, Lars Kuerschner, Heike Weighardt, Irmgard Förster, Christoph Thiele. Kupffer Cells Sense Free Fatty Acids and Regulate Hepatic Lipid Metabolism in High-Fat Diet and Inflammation. Cells 2020; 9(10): 2258 doi: 10.3390/cells9102258
|
| 56 |
Xiao-Yu Luo, Terumi Takahara, Kengo Kawai, Masayuki Fujino, Toshiro Sugiyama, Koichi Tsuneyama, Kazuhiro Tsukada, Susumu Nakae, Liang Zhong, Xiao-Kang Li. IFN-γ deficiency attenuates hepatic inflammation and fibrosis in a steatohepatitis model induced by a methionine- and choline-deficient high-fat diet. American Journal of Physiology-Gastrointestinal and Liver Physiology 2013; 305(12): G891 doi: 10.1152/ajpgi.00193.2013
|
| 57 |
Paloma Almeda-Valdes, Nancy E. Aguilar Olivos, Beatriz Barranco-Fragoso, Misael Uribe, Nahum Méndez-Sánchez. The Role of Dendritic Cells in Fibrosis Progression in Nonalcoholic Fatty Liver Disease. BioMed Research International 2015; 2015: 1 doi: 10.1155/2015/768071
|
| 58 |
Yi Xin, Qin Yuan, Chaoqi Liu, Changcheng Zhang, Ding Yuan. MiR-155/GSK-3β mediates anti-inflammatory effect of Chikusetsusaponin IVa by inhibiting NF-κB signaling pathway in LPS-induced RAW264.7 cell. Scientific Reports 2020; 10(1) doi: 10.1038/s41598-020-75358-1
|
| 59 |
Ia Pantsulaia, Manana Iobadze, Nato Pantsulaia, Tinatin Chikovani. The Effect of Citrus Peel Extracts on Cytokines Levels and T Regulatory Cells in Acute Liver Injury. BioMed Research International 2014; 2014: 1 doi: 10.1155/2014/127879
|
| 60 |
Megan Crane, Kumar Visvanathan, Sharon R. Lewin. HIV Infection and TLR Signalling in the Liver. Gastroenterology Research and Practice 2012; 2012: 1 doi: 10.1155/2012/473925
|
| 61 |
Joseph S. Marino, Jeffrey Iler, Abigail R. Dowling, Streamson Chua, Jens C. Bruning, Roberto Coppari, Jennifer W. Hill, Stephen Franks. Adipocyte Dysfunction in a Mouse Model of Polycystic Ovary Syndrome (PCOS): Evidence of Adipocyte Hypertrophy and Tissue-Specific Inflammation. PLoS ONE 2012; 7(10): e48643 doi: 10.1371/journal.pone.0048643
|
| 62 |
Angelina Mouralidarane, Junpei Soeda, Clara Visconti-Pugmire, Anne-Maj Samuelsson, Joaquim Pombo, Xanthi Maragkoudaki, Adil Butt, Ruma Saraswati, Marco Novelli, Guiseppe Fusai, Lucilla Poston, Paul D. Taylor, Jude A. Oben. Maternal obesity programs offspring nonalcoholic fatty liver disease by innate immune dysfunction in mice. Hepatology 2013; 58(1): 128 doi: 10.1002/hep.26248
|
| 63 |
Noriaki Kawanishi, Hiromi Yano, Tsubasa Mizokami, Masaki Takahashi, Eri Oyanagi, Katsuhiko Suzuki. Exercise training attenuates hepatic inflammation, fibrosis and macrophage infiltration during diet induced-obesity in mice. Brain, Behavior, and Immunity 2012; 26(6): 931 doi: 10.1016/j.bbi.2012.04.006
|
| 64 |
Yong-Hyun Han, Hyeon-Ji Kim, Eun-Jin Kim, Kyu-Seo Kim, Suckchang Hong, Hyeung-Geun Park, Mi-Ock Lee. RORα Decreases Oxidative Stress Through the Induction of SOD2 and GPx1 Expression and Thereby Protects Against Nonalcoholic Steatohepatitis in Mice. Antioxidants & Redox Signaling 2014; 21(15): 2083 doi: 10.1089/ars.2013.5655
|
| 65 |
Mithun Sharma, Shasikala Mitnala, Ravi K. Vishnubhotla, Rathin Mukherjee, Duvvur N. Reddy, Padaki N. Rao. The Riddle of Nonalcoholic Fatty Liver Disease: Progression From Nonalcoholic Fatty Liver to Nonalcoholic Steatohepatitis. Journal of Clinical and Experimental Hepatology 2015; 5(2): 147 doi: 10.1016/j.jceh.2015.02.002
|
| 66 |
Bo-Kyeong Kang, Seung Soo Lee, Hyunhee Cheong, Seung Mo Hong, Kiseok Jang, Moon-Gyu Lee. Shear Wave Elastography for Assessment of Steatohepatitis and Hepatic Fibrosis in Rat Models of Non-Alcoholic Fatty Liver Disease. Ultrasound in Medicine & Biology 2015; 41(12): 3205 doi: 10.1016/j.ultrasmedbio.2015.07.025
|
| 67 |
Yu-Tao Zhan, Hai-Ying Su, Wei An. Glycosyltransferases and non-alcoholic fatty liver disease. World Journal of Gastroenterology 2016; 22(8): 2483-2493 doi: 10.3748/wjg.v22.i8.2483
|
| 68 |
Hwa‐Li Tan, Shamsul Mohd Zain, Hooi‐Sian Eng, Zahurin Mohamed, Sanjiv Mahadeva, Wah‐Kheong Chan, Peng‐Choong Lau, Roma Choudhury Basu, Rosmawati Mohamed. Allele HLA‐DQB1*06 reduces fibrosis score in patients with non‐alcoholic fatty liver disease. Hepatology Research 2020; 50(8): 947 doi: 10.1111/hepr.13525
|
| 69 |
Azalia Mariel Carranza-Trejo, Vaclav Vetvicka, Lucie Vistejnova, Milena Kralickova, Edgar B. Montufar. Hepatocyte and immune cell crosstalk in non-alcoholic fatty liver disease. Expert Review of Gastroenterology & Hepatology 2021; 15(7): 783 doi: 10.1080/17474124.2021.1887730
|
| 70 |
So Hyung Hong, Ki Tae Suk, Sang Hyeon Choi, Jung Wook Lee, Ho Taik Sung, Chang Hoon Kim, Eun Ji Kim, Myoung Jo Kim, Sang Hak Han, Moon Young Kim, Soon Koo Baik, Dong Joon Kim, Gyoung-Ja Lee, Sang-kyu Lee, Seung Ha Park, Ohk Hyun Ryu. Anti-oxidant and natural killer cell activity of Korean red ginseng (Panax ginseng) and urushiol (Rhus vernicifera Stokes) on non-alcoholic fatty liver disease of rat. Food and Chemical Toxicology 2013; 55: 586 doi: 10.1016/j.fct.2013.01.022
|
| 71 |
Ashley Eheim, Dasa Medrikova, Stephan Herzig. Immune cells and metabolic dysfunction. Seminars in Immunopathology 2014; 36(1): 13 doi: 10.1007/s00281-013-0403-7
|
| 72 |
Mariana Verdelho Machado, Helena Cortez-Pinto. Non-alcoholic fatty liver disease: What the clinician needs to know. World Journal of Gastroenterology 2014; 20(36): 12956-12980 doi: 10.3748/wjg.v20.i36.12956
|